PPARG and breast carcinoma: In contrast to breast carcinoma cells, pan-HDAC blockade with LBH589 did not upregulate PPARγ expression or augment its activity in untransformed human breast epithelial cell lines MCF10A and MCF12A (Fig. S8A, B).